Chen Biao-Qi, Zhao Yi, Zhang Yang, Pan Yu-Jing, Xia Hong-Ying, Kankala Ranjith Kumar, Wang Shi-Bin, Liu Gang, Chen Ai-Zheng
Institute of Biomaterials and Tissue Engineering, Fujian Provincial Key Laboratory of Biochemical Technology, Huaqiao University, Xiamen, 361021, PR China.
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, PR China.
Bioact Mater. 2022 Aug 10;21:1-19. doi: 10.1016/j.bioactmat.2022.07.023. eCollection 2023 Mar.
Although nano-immunotherapy has advanced dramatically in recent times, there remain two significant hurdles related to immune systems in cancer treatment, such as (namely) inevitable immune elimination of nanoplatforms and severely immunosuppressive microenvironment with low immunogenicity, hampering the performance of nanomedicines. To address these issues, several immune-regulating camouflaged nanocomposites have emerged as prevailing strategies due to their unique characteristics and specific functionalities. In this review, we emphasize the composition, performances, and mechanisms of various immune-regulating camouflaged nanoplatforms, including polymer-coated, cell membrane-camouflaged, and exosome-based nanoplatforms to evade the immune clearance of nanoplatforms or upregulate the immune function against the tumor. Further, we discuss the applications of these immune-regulating camouflaged nanoplatforms in directly boosting cancer immunotherapy and some immunogenic cell death-inducing immunotherapeutic modalities, such as chemotherapy, photothermal therapy, and reactive oxygen species-mediated immunotherapies, highlighting the current progress and recent advancements. Finally, we conclude the article with interesting perspectives, suggesting future tendencies of these innovative camouflaged constructs towards their translation pipeline.
尽管纳米免疫疗法近年来取得了显著进展,但在癌症治疗中与免疫系统相关仍存在两个重大障碍,即纳米平台不可避免地被免疫清除以及具有低免疫原性的严重免疫抑制微环境,这阻碍了纳米药物的性能。为了解决这些问题,几种免疫调节伪装纳米复合材料因其独特的特性和特定功能而成为流行策略。在这篇综述中,我们强调了各种免疫调节伪装纳米平台的组成、性能和机制,包括聚合物包覆、细胞膜伪装和基于外泌体的纳米平台,以逃避纳米平台的免疫清除或上调针对肿瘤的免疫功能。此外,我们讨论了这些免疫调节伪装纳米平台在直接促进癌症免疫治疗和一些诱导免疫原性细胞死亡的免疫治疗方式(如化疗、光热疗法和活性氧介导的免疫疗法)中的应用,突出了当前的进展和最新成果。最后,我们以有趣的观点结束本文,提出这些创新伪装构建体在其转化流程方面的未来趋势。
Acc Chem Res. 2024-3-19
Acta Pharmacol Sin. 2020-7
Asian J Pharm Sci. 2020-7
Nanomaterials (Basel). 2024-2-23
Acc Chem Res. 2020-12-15
Acta Pharm Sin B. 2025-1
BioTechnologia (Pozn). 2024-12-19
Theranostics. 2025-1-1
Hum Vaccin Immunother. 2024-12-31
Front Pharmacol. 2024-7-31
J Control Release. 2022-5
Acta Pharm Sin B. 2022-1
Nanoscale Horiz. 2022-1-31
Colloids Surf B Biointerfaces. 2022-1
Natl Sci Rev. 2019-5
J Control Release. 2021-10-10